SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHydrogenOne Regulatory News (HGEN)

  • There is currently no data for HGEN

Initiation from QuotedData

3 May 2023 17:19

RNS Number : 3288Y
HydrogenOne Capital Growth PLC
03 May 2023
 

HydrogenOne Capital Growth - Initiation from QuotedData

3rd May 2023

Funding a green revolution

HydrogenOne Capital Growth (HGEN) is the only pure play green (renewables-powered, no carbon dioxide produced) hydrogen fund available on the London listed market. It offers diverse exposure to nine exciting private hydrogen investments and a hydrogen production facility that is being developed in Germany.

Spurred on by the need to tackle climate change and improve energy security, globally, governments are devoting considerable resources to jump-starting the green hydrogen industry. HGEN is well-positioned to benefit as investee businesses scale rapidly over the coming years. The investment adviser has around £500m worth of additional opportunities available.

HGEN should be seen as a long-term investment. However, in the short-term, more risk-averse (some might say panicky) investors have driven a sharp, and we feel unwarranted, fall in HGEN's share price. With the shares at an 51.9% discount, new investors are being presented with an attractive entry point.

Full Research:

https://quoteddata.com/research/hydrogenone-capital-growth-funding-green-revolution-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on HydrogenOne Capital Growth Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDULBGDGXX
Date   Source Headline
30th Apr 20267:00 amRNSAdmission to JP Jenkins Trading Platform
23rd Apr 20265:00 pmRNSHolding(s) in Company
30th Mar 20264:00 pmRNSResult of General Meeting
26th Mar 202610:51 amRNSChange of Venue and Time of General Meeting
26th Mar 202610:49 amRNSHolding(s) in Company
19th Mar 202612:15 pmRNSHolding(s) in Company
17th Mar 202610:04 amRNSHolding(s) in Company
13th Mar 20264:45 pmRNSHolding(s) in Company
12th Mar 202611:13 amRNSNotice of GM
9th Mar 20267:00 amRNSPartial Sale of Stake in Strohm
27th Feb 20264:42 pmRNSHolding(s) in Company
9th Feb 20265:00 pmRNSNet Asset Value(s)
1st Dec 20252:24 pmRNSGeneral Meeting Results
27th Nov 20256:20 pmRNSHolding(s) in Company
18th Nov 20258:25 amRNSRestoration of Listing & Trading
13th Nov 20257:05 amRNSQ3 2025 Net Asset Value
13th Nov 20257:00 amRNSHalf-year Financial Report
12th Nov 20256:00 pmRNSHydrogen Capital Growth
6th Nov 20254:55 pmRNSPortfolio Update - Bramble Energy Limited
29th Oct 20257:00 amRNSNotice of GM
18th Sep 20257:49 amRNSSuspension of Listing and Company Update
18th Sep 20257:30 amRNSSuspension - Hydrogen Capital Growth plc
31st Jul 20255:34 pmRNSChange of Name
30th Jul 20257:00 amRNSCOMPANY UPDATE AND APPOINTMENT OF REDWHEEL
27th Jun 20253:22 pmRNSResult of AGM
24th Jun 20254:14 pmRNSHolding(s) in Company
3rd Jun 20253:36 pmRNSPosting of Circular and Notice of AGM
14th May 20257:00 amRNS-RPublication of annual hydrogen sector review
14th May 20257:00 amRNSQ1 2025 NAV and Portfolio Update
12th May 20257:00 amRNSNotice of Financial Adviser & Corporate Broker
9th May 20257:00 amRNSQ1 NAV, Portfolio Update & Investor Presentation
30th Apr 202510:06 amRNSAnnual Results - Correction
30th Apr 20259:41 amRNS-RUpdate: Notice of Webcast
30th Apr 20257:00 amRNS-RPublication of 2024 Sustainability Report
30th Apr 20257:00 amRNSAnnual Results
25th Apr 20257:00 amRNSNotice of Results
10th Apr 20259:19 amRNSInvestment Advisor Update
21st Mar 20256:16 pmRNSDirectorate Change
10th Mar 20257:00 amRNS-RElcogen announces SYRIUS Project in green steel
28th Feb 20257:00 amRNS-RQuotedData's Weekly News Show
21st Feb 20257:00 amRNS-RSunfire: Finnish hydrogen plant online
5th Feb 20257:00 amRNSQ4 2024 Net Asset Value and Portfolio Update
3rd Feb 20257:00 amRNSNotice of NAV and Portfolio Update
17th Jan 20257:00 amRNSElcogen secures €5 mn investment from SmartCap
9th Jan 20257:00 amRNSSunfire secures €200m in Guaranteed Financing
12th Dec 20249:51 amRNS-RFlash note form QuotedData
11th Dec 20247:00 amRNSInvestment Adviser acquisition by Cordiant
20th Nov 20247:00 amRNS-RSunfire awarded a new 50 MW electrolyser contract
18th Nov 20247:00 amRNSChange of Registered Office
14th Nov 20247:00 amRNSPortfolio Update - HH2E

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.